Immediate Impact
65 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Luwen Mu being referenced
Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma
2020
Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Luwen Mu | 385 | 221 | 163 | 23 | 629 | |
| Akhil Chopra | 331 | 342 | 78 | 27 | 723 | |
| Guoliang Shao | 365 | 148 | 85 | 32 | 527 | |
| Chang‐Jun Tan | 329 | 177 | 165 | 27 | 689 | |
| Bowen Zhu | 338 | 167 | 66 | 21 | 563 | |
| Francesca Benevento | 293 | 138 | 92 | 19 | 685 | |
| Vikki Tang | 555 | 181 | 195 | 18 | 694 | |
| Linjing An | 379 | 128 | 96 | 19 | 586 | |
| Oxana V. Makarova‐Rusher | 266 | 327 | 105 | 17 | 695 | |
| Yong‐Fa Zhang | 379 | 156 | 168 | 31 | 629 | |
| Donald Poon | 242 | 222 | 103 | 19 | 681 |
All Works
Login with ORCID to disown or claim papers
Loading papers...